Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

41 results about "Forsythoside A" patented technology

Application of forsythiaside A in preparing medicine for treating ACLY related diseases or medicine for inhibiting ACLY activity and medicine composition

The invention discloses an application of forsythiaside A in preparation of an ATP (adenosine triphosphate) citrate lyase (ACLY) inhibitor. In an enzyme activity test, the forsythiaside A has a very significant inhibition effect on ACLY, and the median inhibitory concentration (IC50) is 0.64 + / -0.09 [mu] M; on a cell model, the forsythiaside A can obviously reduce the triglyceride level; animal experiments show that forsythiaside A can reduce the weight, blood sugar, triglyceride, cholesterol level and the like of mice fed by high-fat, high-cholesterol and high-fructose feed. Therefore, the forsythoside A has a potential treatment value on ACLY related diseases, such as hyperlipidemia and atherosclerosis.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Recombinant escherichia coli for de novo synthesis of forsythiaside A

The invention relates to the technical field of synthetic biology and microbial engineering, in particular to recombinant escherichia coli for de novo synthesis of forsythiaside A. The invention provides recombinant escherichia coli for de novo synthesis of forsythiaside A. A preparation method of the recombinant escherichia coli comprises a step of improving an escherichia coli starting strain, and the escherichia coli starting strain is escherichia coli MG1655. In the fermentation process of the recombinant escherichia coli, effective accumulation of forsythiaside A in fermentation liquor can be achieved, and a foundation can be laid for subsequent construction of high-yield forsythiaside A engineering bacteria.
Owner:SHENZHEN RESEARCH INSTITUTE OF NORTHWEST A & F UNIVERSITY

Mixed traditional Chinese medicine feed additive capable of resisting bee mites and preparation method of mixed traditional Chinese medicine feed additive

The invention relates to a mixed traditional Chinese medicine feed additive for resisting bee mites and a preparation method thereof, and belongs to the technical field of healthy breeding of bees and pest control. The feed additive comprises a radix stemonae extract obtained by compound extraction of radix stemonae, radix sophorae flavescentis and areca catechu, and a syrup matrix composed of ammonium glycyrrhizinate, vitamin C, pachymaran, honey and apple vinegar, when necessary, synergetic components such as forsythiaside, menthol and carboxymethyl chitosan are further added, and microcapsule embedding treatment is performed to enhance the slow release performance. The formula is natural, safe and good in palatability, can effectively prevent and control invasion of Varroa destructor of bee colonies and improve the survival rate of the bee colonies, has a good slow-release effect and oral administration adaptability, and is suitable for long-term stable use in bee farms.
Owner:SHANXI HENGDA LEIAO BIOLOGICAL TECH CO LTD

Temperature-controlled anti-inflammatory and antibacterial skin wound dressing capable of promoting revascularization as well as preparation method and application thereof

The invention discloses a temperature-controlled anti-inflammatory and antibacterial skin wound dressing capable of promoting revascularization and a preparation method and application thereof, and relates to the technical field of medical materials, the preparation method comprises the following steps: S1, preparing calcium peroxide microspheres; s2, the poloxamer 407, the chitosan and the forsythiaside A are jointly dissolved in an acetic acid solution, and mixed gel is obtained; s3, dispersing calcium peroxide microspheres into the mixed gel to obtain the skin wound dressing capable of controlling temperature, resisting inflammation and bacteria and promoting revascularization. The traditional Chinese medicine active ingredient forsythiaside A is loaded, so that the healing efficiency of diabetic wounds is improved; due to the temperature-sensitive property of the gel, the gel can be better attached to the wound, the antibacterial property can inhibit microorganism breeding at the wound surface, the oxygen release capacity can improve the anoxic environment at the wound, and the loaded traditional Chinese medicine active ingredient forsythiaside A has the anti-inflammatory capacity, promotes cell regeneration at the wound and accelerates the repair process.
Owner:HUBEI UNIV OF MEDICINE

Forsythia suspense processing technology and processed forsythia suspense

PendingCN119970838APlant ingredientsGlycosideForsythide
The invention relates to the technical field of traditional Chinese medicine processing, and particularly discloses a fructus forsythiae processing technology and processed fructus forsythiae. The fructus forsythiae processing technology comprises the following steps: putting a crude fructus forsythiae product in steam generated after boiling of heated ultrapure water in a pressurized environment, controlling the steam temperature to be 120-150 DEG C, performing steam fixation for 8-12 minutes, and drying the fructus forsythiae subjected to steam fixation to obtain processed fructus forsythiae. According to the processed fructus forsythiae obtained through the processing technology, the content of forsythin in the processed fructus forsythiae reaches 0.78% or above, the content of forsythiaside A reaches 2.65% or above, and the overall quality and the medicine effect of the fructus forsythiae are remarkably improved.
Owner:SHANXI KANGYI HENGTAI PHARM CO LTD

Application of forsythiaside A in preparation of medicine for relieving or treating diabetic cardiomyopathy

The invention belongs to the field of biological medicine, and particularly relates to application of forsythiaside A in preparation of a medicine for relieving or treating diabetic cardiomyopathy. The forsythiaside A relieves or treats diabetic cardiomyopathy by regulating NLRP3 activation induced by endoplasmic reticulum stress. The forsythiaside A can reduce the levels of BG, GSP, TG, LDH, CK-MB, cTnI, MDA, IL-1beta, IL-6 and TNF-alpha of STZ induced diabetic mice, and meanwhile, the levels of IN and SOD are increased. The forsythiaside A can be used for reducing the expression levels of IL-1beta, IL-6, TNF-alpha, GRP78, TXNIP and NLRP3 in H9c2 cells induced by Glu. Therefore, forsythiaside A can induce NLRP3 inflammasome activation through endoplasmic reticulum stress to relieve diabetic cardiomyopathy, and a theoretical basis is provided for treating diabetic cardiomyopathy.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Application of two phenylethanoid glycoside compounds in ponsamie in anti-hepatitis B virus and liver protection

The invention relates to the technical field of chemistry and medicine, in particular to application of two phenylethanoid glycoside compounds in Pensamie in anti-hepatitis B virus and liver protection, including application of forsythiaside F and forsythiaside B in preparation of anti-hepatitis B virus drugs and / or application of forsythiaside F and forsythiaside B in preparation of liver protection drugs. According to the invention, two compounds of forsythiaside F and forsythiaside B are obtained from 75% ethanol extract of separated and purified Tibesimie, the properties of the two compounds are researched, and the two compounds are found to be capable of reducing HBsAg and HBeAg and have a certain liver protection effect, so that data are provided for development and utilization of Tibesimie and research and development of anti-hepatitis B virus drugs, and the research and development of the Tibesimie and the research and development of the anti-hepatitis B virus drugs are facilitated. And a new way is provided for HBV prevention and treatment.
Owner:GUILIN MEDICAL UNIVERSITY

Method for determining content of fructus forsythiae component in children lung heat cough and asthma granules

The invention discloses a method for determining the content of fructus forsythiae in children lung heat cough and asthma granules, which comprises the following steps: step 1, precisely weighing forsythiaside A, forsythiaside H and forsythiaside I, and adding 50v / v% methanol solution for dissolving to obtain a mixed reference solution; 2, precisely weighing the ground sample to be detected, adding a 50v / v% methanol solution, carrying out ultrasonic treatment, cooling, weighing, complementing the reduced weight with the 50v / v% methanol solution, filtering, and taking a subsequent filtrate to obtain a test solution; and step 3, adopting high performance liquid chromatography, and carrying out sample injection detection. According to the method, the content of the fructus forsythiae related components in the infantile lung-heat cough and asthma granules is simultaneously determined by adopting the high performance liquid chromatography, the method is simple, reliable, good in durability, advanced and feasible, and the purpose of effectively controlling the quality of the fructus forsythiae related components in the infantile lung-heat cough and asthma granules is achieved; and a technical basis can be provided for internal quality control of pharmaceutical production enterprises and quality standard improvement of supervision departments.
Owner:HEILONGJIANG KUIHUA PHARMA

Bone-targeting forsythiaside A-loaded exosome as well as preparation method and application thereof

The invention discloses a bone targeting forsythiaside A loaded exosome and a preparation method and application thereof, and relates to the technical field of biomedicine.The preparation method comprises the following steps that bone marrow mesenchymal stem cells are separated and cultured, and GLG1 is over-expressed through a molecular cloning technology to obtain GLG1-BMSCs; the exosome GLG1-Exos of the GLG1-BMSCs is collected through an ultracentrifugation method; and loading forsythiaside A into the exosome through an ultrasonic method and an extrusion method to obtain the GLG1-Exos-FTA. The traditional Chinese medicine active ingredient forsythiaside A is loaded, and forsythiaside A is delivered to bone marrow in a targeted manner, so that the effect of preventing and improving diabetic osteoporosis is achieved; due to the targeting effect, the bioavailability of forsythiaside A can be enhanced, and meanwhile, the curative effect of resisting diabetic osteoporosis is improved. Experiments show that the loading rate of forsythiaside A of the GLG1-Exos-FTA reaches 36.9%, the particle size distribution peak value is 122.4 nm, and the GLG1-Exos-FTA has typical exosome characteristics and bone targeting, and can significantly improve the bone microstructure of diabetic osteoporosis mice.
Owner:HUBEI UNIV OF MEDICINE +1

Traditional Chinese medicine composition for removing acnes

The invention relates to the technical field of traditional Chinese medicine compositions, and provides a traditional Chinese medicine composition for removing acnes, which is prepared from the following components in parts by weight: 1-2 parts of honeysuckle stem extract, 0.3-0.8 part of fructus forsythiae extract, 2-4 parts of radix scutellariae extract, 0.5-3.5 parts of cortex magnoliae officinalis extract and 1-5 parts of astragalus complanatus extract. The preparation method of the fructus forsythiae extract comprises the following steps: crushing fructus forsythiae, performing steam explosion treatment to obtain pretreated fructus forsythiae, adding water, adding biological compound enzyme, performing enzymolysis, filtering and performing enzyme deactivation to obtain filtrate; enabling the filtrate to pass through macroporous resin, washing with water, carrying out first elution to obtain a solution I, and carrying out second elution to obtain a solution II; performing post-treatment on the solution I to obtain forsythiaside; performing post-treatment on the solution II to obtain forsythin; the biological compound enzyme comprises alpha-galactosidase, lipase and xylanase. Through the technical scheme, the problem of low extraction rate of forsythin and forsythiaside in fructus forsythiae in the prior art is solved.
Owner:HEBEI TIDU BIOTECHNOLOGY GRP CO LTD

Construction method and detection method of traditional Chinese medicine high performance liquid fingerprint

The invention provides a construction method and a detection method of a high performance liquid fingerprint of granules for consolidating foundation and clearing away lung-heat. According to the construction method, high performance liquid fingerprint spectrums of a test solution and a reference solution of the primordial qi-consolidating and lung-heat-clearing granules are compared, so that the main effective active substances of the primordial qi-consolidating and lung-heat-clearing granules are detected. The reference substance solution is prepared from 3 '-hydroxy puerarin, puerarin, 3'-methoxy puerarin, puerarin-6 ''-O-xyloside, puerarin apigenin, daidzin, forsythiaside A, pinoresinol-4-O-glucopyranoside, baicalin, forsythin, wogonoside, baicalein and the like. Finally, a high-performance liquid-phase fingerprint spectrum technical standard of the primordial qi-consolidating and lung-heat-clearing granules is established, the quality of the primordial qi-consolidating and lung-heat-clearing granules can be effectively and comprehensively monitored according to the characteristics of existence of common peaks in the fingerprint spectrum, and the method has the characteristics of good stability, good repeatability and strong operability.
Owner:SHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL

Determination method of five components in Toujiequwen preparation and its application

The present invention discloses a method for determining the contents of five components in a Toujie Quwen preparation and its application, wherein the method comprises the following steps: firstly subjecting a test solution of the Toujie Quwen preparation to be tested to HPLC detection to obtain the content of forsythin; and then determining the content of five components in a Toujie Quwen preparation according to the formula (C i / W)×(A r / A i )×V×D×F i / r , calculate the contents of forsythiaside I, forsythiaside A, (+) pinoresinol-β-D-pyranoglucoside and forsythiaside in the tested Toujie Quwen preparation. The present invention establishes a method for determining the contents of multiple components of Toujie Quwen preparation by a one-test-multiple-evaluation method, which greatly improves the quality control level of Toujie Quwen preparation, and also meets the needs of relevant scientific connotation research. The method of the present invention is highly practical, cost-saving, stable and controllable.
Owner:GUANGZHOU BAIYUSN HUTCHISON WHAMPOA CHINESE MEDICINE

Establishment method and application method of fingerprint spectrum of honeysuckle and fructus forsythiae mixture

The invention discloses an establishment method and an application method of a fingerprint spectrum of a honeysuckle and fructus forsythiae mixture, and belongs to the technical field of detection of effective components of traditional Chinese medicine, and the establishment method comprises the following steps: S1, determining chromatographic conditions; s2, preparing a test solution and a mixed reference solution; s3, collecting chromatograms of the test sample and the mixed reference substance; and S4, matching common peaks, calculating the relative retention time and the relative peak area of each common peak, comparing with the chromatogram of the reference substance, identifying the common peaks, and establishing the fingerprint spectrum of the honeysuckle and fructus forsythiae mixture. According to the establishment method of the fingerprint spectrum of the honeysuckle and fructus forsythiae mixture, reference and basis are provided for quality control of the honeysuckle and fructus forsythiae mixture, and the establishment method has the advantages of being simple, convenient, stable, high in precision, good in reproducibility and the like. The fingerprint spectrum has 11 effectively separated common peaks, identifies the characteristic peaks of neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, liquiritin and forsythiaside A, can reflect the condition of the effective components of the honeysuckle and fructus forsythiae mixture, and effectively characterizes the quality of the honeysuckle and fructus forsythiae mixture.
Owner:山东宏济堂制药集团股份有限公司

Method for establishing fingerprint spectrum of lianqin zhenzhu dripping pill

A method for establishing a fingerprint spectrum of a Lianqin Zhenzhu dripping pill, the method comprising determining active ingredients in a Lianqin Zhenzhu dripping pill by means of high-performance liquid chromatography, wherein the extraction solvent for the Lianqin Zhenzhu dripping pill is methanol-water, and the active ingredients include baicalin, geniposide, forsythiaside A and glycyrrhizic acid. By using the method for establishing a fingerprint spectrum of a Lianqin Zhenzhu dripping pill, the active ingredients in the preparation can be effectively extracted, and the main ingredients of the Lianqin Zhenzhu dripping pill can be effectively characterized. The method enables the rapid and accurate identification of the authenticity and uniformity of a finished preparation, and is of great significance for comprehensively controlling the quality of a product.
Owner:SUZHOU SIXTH PHARMA PLANT OF JIANGSU WUZHONG PHARMA GROUP

Application of forsythiaside A in preparation of inhibitor for treating methicillin-resistant staphylococcus aureus Stp1

The invention discloses an application of forsythiaside A in preparation of an inhibitor for treating methicillin-resistant staphylococcus aureus Stp1. Firstly, an Stp1 protein is purified for an Stp1 phosphatase activity experiment, and it is found that the protein activity is reduced along with increase of the drug concentration, and the IC50 value is 2.673 micrograms / mL. Then, the forsythiaside A with different concentrations and the USA300 strain are co-cultured, and it is found that the forsythiaside A cannot inhibit growth of the USA300 strain. In addition, in-vitro experiments show that forsythiaside A shows a good cell protection effect, and staphylococcus aureus mediated cell damage is effectively relieved; in-vivo experiments show that the forsythiaside A relieves infection caused by methicillin-resistant staphylococcus aureus, and lesions of main organs (liver, kidney and lung) of mice are improved. Therefore, the forsythiaside A does not cause the generation of bacterial drug resistance by targeting the staphylococcus aureus Stp1, and has important significance in the aspect of treating infection caused by methicillin-resistant staphylococcus aureus.
Owner:JILIN UNIVERSITY

Forsygenin glucosamine and preparation method and application thereof

The invention belongs to the technical field of medicines, and particularly relates to forsythiaside glucosamine, a preparation method thereof and application of the forsythiaside glucosamine in treatment of osteoarthritis. The invention relates to design and synthesis of forsythiaside glucosamine, and researches on the treatment effect of forsythiaside glucosamine on an osteoarthritis mouse model. In the structural general formula of the compound, R1 is an amino group, a phthaloyl amino group or an allyloxy amido group, R2, R3 and R4 groups represent a hydroxyl group or an alkanoyloxy group, and the configurations of different head positions are alpha and beta. Wherein the alkanoyloxy group is a C1-C6 alkanoyloxy group or a deuterated alkanoyloxy group. The synthesized forsythiaside glucosamine is used as a twin drug, and shows better cartilage generation promoting activity and anti-inflammatory activity compared with combined use of forsythiaside and glucosamine on an osteoarthritis mouse model. In addition, under the same administration dosage, the activity of promoting cartilage generation and the like is obviously superior to that of forsythiaside acetylglucosamine in the prior art.
Owner:SHANGHAI JINSI BIOTECHNOLOGY CO LTD

Application of forsythiaside in preparation of medicine for preventing or / and treating cerebral arterial thrombosis

The invention relates to application of forsythiaside in treating cerebral arterial thrombosis, and belongs to the technical field of biological medicine. The phillygenin is a small molecule compound extracted from traditional Chinese medicine fructus forsythiae, can be transported into the brain through LILRA5 protein on the surface of peripheral blood mononuclear cells, acts on astrocytes, inhibits combination of PTP1B and FGFR1, enhances phosphorylation of FGFR1, and activates a downstream protective signal channel, so that the neuroprotective effect is achieved. Experiments show that forsythiaside can significantly reduce the volume of cerebral infarction and improve neurological impairment. The invention provides new candidate molecules and mechanism targets for the drug treatment of cerebral arterial thrombosis.
Owner:SHENGJING HOSPITAL OF CHINA MEDICAL UNIVERSITY

Injectable hydrogel for pet endometritis as well as preparation method and application of injectable hydrogel

PendingCN119074643AImprove antibacterial propertiesReduce the chance of secondary infectionOrganic active ingredientsAerosol deliveryEndarteritisSodium phosphates
The invention provides injectable hydrogel for pet endometritis, and belongs to the technical field of veterinary drug preparation. The injectable hydrogel prepared by the invention is prepared from the following raw materials: forsythiaside A, chitosan, beta-sodium glycerophosphate, sodium hyaluronate, acetic acid and water. By combining the technical advantages of a temperature-sensitive gel technology and an injectable gel technology, forsythiaside A and chitosan are combined for use, so that the injectable hydrogel with excellent antibacterial performance is obtained. The forsythiaside A is wrapped by the chitosan, so that the antibacterial effect of the forsythiaside A is enhanced, the release time of the medicine is prolonged, the time required for repairing the inflammatory injury can be effectively shortened, and the probability of secondary infection in the uterine cavity is reduced.
Owner:TARIM UNIV

Method for determining contents of forsythiaside E and rutin in phlegm-heat-clearing injection

The invention discloses a method for determining the content of forsythiaside E and rutin in a phlegm-heat-clearing injection, which comprises the following steps: a test solution and a reference solution are taken for detection, the phlegm-heat-clearing injection is composed of scutellaria baicalensis, bear gall powder, cornu gorais, honeysuckle, fructus forsythiae and propylene glycol, the reference solution is forsythiaside E and rutin, and the reference solution is composed of propylene glycol. Chromatographic conditions of the detection are as follows: a chromatographic column with octadecylsilane chemically bonded silica as a filler is adopted, a mobile phase A is selected from one or more of acetonitrile, methanol and tetrahydrofuran, and a mobile phase B is an acid aqueous solution, an alkali aqueous solution and / or a buffer salt aqueous solution; and obtaining content information of forsythiaside E and rutin in the phlegm-heat-clearing injection according to a detection result. The method disclosed by the invention is simple, convenient, efficient and rapid, and provides a theoretical basis for the quality control of the phlegm-heat-clearing injection and the deep research of a pharmacodynamic material basis by detecting the contents of forsythiaside E and rutin in the phlegm-heat-clearing injection.
Owner:SHANGHAI KAIBAO PHARMACEUTICAL CO LTD

A composition for enhancing immunity and resistance to pathogen infection and its use therein.

This invention belongs to the pharmaceutical field, specifically relating to a composition for enhancing innate immunity and exerting anti-infective effects, and its uses. Specifically, this invention selects ALOX15 enzyme activity inhibitors, including baicalin; compounds that promote ALOX15 transcriptional activity, including aconitine; and compounds that inhibit ALOX15 protein degradation, including forsythoside A / E / I, and combines them in a multi-strategy scientific formulation. Experimental studies have shown that the composition containing ALOX15 enzyme activity inhibitors, ALOX15 transcriptional activity promoters, and ALOX15 protein degradation inhibitors can effectively enhance the body's innate immunity, increase the synthesis and secretion of IFN-β, and exert anti-pathogen infection effects. The composition of this invention can also inhibit the production of pathogen-induced inflammatory factors and has a therapeutic effect on pathogen-induced secondary inflammatory symptoms, showing great promise for clinical application.
Owner:JINAN UNIVERSITY

Fingerprint detection method for shuanghuanglian traditional Chinese medicine composition and application thereof

The application belongs to the technical field of traditional Chinese medicines, and discloses a fingerprint spectrum detection method of Shuanghuanglian traditional Chinese medicine composition and application thereof. The fingerprint spectrum detection method is as follows: high performance liquid chromatography is used to analyze test sample solution and control sample solution; and a fingerprint spectrum is obtained by processing the color spectrum by using a fingerprint spectrum software; in the liquid chromatography analysis, gradient elution is performed by using a mobile phase, and the mobile phase is as follows: the A phase includes phosphoric acid aqueous solution, and the B phase includes acetonitrile and methanol. The fingerprint spectrum detection method can calibrate at least 22 chromatographic peaks under different detection wavelengths, and identify 10 kinds of effective components such as forsythia ester glycoside E, chlorogenic acid and coffee acid, and simultaneously perform quantitative analysis on multiple components; the fingerprint spectrum detection method can make each batch of medicines have stable and reliable therapeutic effects. The Shuanghuanglian traditional Chinese medicine composition screened by the quality control and having specific active component content characteristics can be used for preparing medicines for reducing susceptibility to influenza.
Owner:HENAN XICHUAN COUNTY FUSEN PHARM CO LTD

Injectable hydrogel for pet endometritis, and preparation method and use thereof

An injectable hydrogel for pet endometritis is provided, belonging to the technical field of veterinary drug preparation. The injectable hydrogel includes the following raw materials: forsythiaside A, chitosan, sodium β-glycerophosphate, sodium hyaluronate, acetic acid, and water. By combining the technical advantages of thermosensitive gel with injectable gel, forsythiaside A is used in combination with the chitosan to obtain an injectable hydrogel with excellent antibacterial properties. Encapsulating forsythiaside A with the chitosan not only enhances an antibacterial effect of forsythiaside A, but also prolongs a release time of the drug and can effectively shorten a duration required for repairing inflammatory damages, thereby reducing the probability of secondary infection in the uterine cavity.
Owner:TARIM UNIV

Application of forsythiaside A in treatment of bacterial infectious pneumonia

The invention belongs to the technical field of medicine. The invention discloses an application of forsythiaside A in preparation of a medicine for treating bacterial infectious pneumonia. The method comprises the following steps: firstly, establishing a model of mice bacterial infectious pneumonia caused by tracheal intubation instillation of Pseudomonas aeruginosa in vivo, and applying forsythiaside A to treat, so that the infection symptom of the model mice can be obviously relieved, and the lung inflammatory response can be effectively relieved. The method comprises the following steps: firstly, establishing a model of pulmonary alveolar macrophages infected with Pseudomonas aeruginosa, Klebsiella pneumoniae or Acinetobacter baumannii in vitro, and then, establishing a model of pulmonary alveolar macrophages infected with Pseudomonas aeruginosa, Klebsiella pneumoniae or Acinetobacter baumannii in vitro, so that after forsythiaside A is added, the damage of the macrophages can be effectively alleviated, and the number of infectious bacteria in cytoplasm can be reduced. Experimental results show that forsythiaside A can be effectively used for treating bacterial infectious pneumonia.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

Construction and quality control of lung-tonifying and detoxifying granule fingerprint spectrum

The invention relates to construction and quality control of a lung-tonifying and detoxifying granule fingerprint spectrum. An HPLC (High Performance Liquid Chromatography) fingerprint spectrum of the lung-tonifying and detoxifying granules has 17 characteristic fingerprint chromatographic peaks, wherein the peak 1 is guanosine, the peak 3 is protocatechualdehyde, the peak 4 is quinic acid, the peak 6 is chlorogenic acid, the peak 10 is loganin, the peak 14 is forsythiaside A, and the peak 17 is forsythin.
Owner:SHAANXI PROVINCIAL HOSPITAL OF CHINESE MEDICINE

Application of forsythin in preparation of medicine for preventing or treating heart failure complicated by insulin resistance

The invention discloses application of forsythin in preparation of a medicine for preventing or treating heart failure complicated by insulin resistance, and relates to the technical field of biomedicine. According to the invention, a model animal C57BL / 6J mouse is taken as a carrier, and the treatment effect of forsythin on heart failure complicated by insulin resistance is researched. The invention researches that forsythin has the effects of improving glucose intolerance and insulin resistance of a heart failure complicated insulin resistance model mouse and reducing the serum insulin level of the heart failure complicated insulin resistance model mouse; the sensitivity of muscle, adipose tissue, heart and liver insulin signal channels of a heart failure complicated insulin resistance model mouse is improved. It is proved that forsythin can effectively prevent and treat insulin resistance caused by heart failure, and a new selection thought is provided for prevention or treatment of insulin resistance complicated by heart failure at present.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE +1

Use of forsythoside a in preparation of medicine for preventing edema caused by rosiglitazone

The application discloses application of forsythoside in preparation of a medicine for preventing edema caused by rosiglitazone, and belongs to the technical field of biological medicine. In view of the problem that rosiglitazone can cause edema side effect when treating type 2 diabetes, the application uses forsythoside and rosiglitazone in combination, rosiglitazone can relieve type 2 diabetes, and forsythoside can effectively reduce edema caused by rosiglitazone, so that the side effect of rosiglitazone medicine can be obviously reduced, and the dosage of rosiglitazone can be reduced. The application provides a new safe and effective medicine combination for treating and preventing insulin resistance diseases, and provides a theoretical guidance for preventing and treating the edema side effect of rosiglitazone.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Application of cryptochlorogenic acid in preparation of medicine for preventing and treating RSV (Respiratory Syndrome Virus) infection

The invention discloses application of cryptochlorogenic acid in preparation of a medicine for preventing and treating RSV (Respiratory Syndrome Virus) infection, and belongs to the technical field of biology. The invention focuses on a multi-component synergistic mechanism of the anti-virus effect of the Yinqiao drug pair, takes a targeted ACSL4 protein as an entry point, researches the pharmacodynamic material basis of the Yinqiao drug pair by combining SPR affinity fishing with computational chemistry, and finds that the Yinqiao drug pair contains nine active components capable of being combined with the ACSL4 protein. Subsequently, a molecular docking and dynamic simulation technology is adopted to verify the combination mode of the active ingredients and proteins, the combination of the key ingredients of chlorogenic acid and forsythiaside is more stable, cryptochlorogenic acid becomes a key pharmacodynamic substance for regulating lipid peroxidation and playing an antiviral role, and cryptochlorogenic acid and forsythiaside become a key pharmacodynamic substance for regulating lipid peroxidation and playing an antiviral role. Research results provide theoretical basis and data support for traditional Chinese medicine prevention and treatment of RSV virus infectious diseases and research and development of traditional Chinese medicine targeted drugs.
Owner:SHANDONG ACAD OF CHINESE MEDICINE

Method for extracting forsythiaside A and forsythin by deep eutectic solvent method and application of forsythiaside A and forsythin

The invention relates to a method for extracting forsythiaside A and forsythin through a deep eutectic solvent method and application of the forsythiaside A and the forsythin. The method comprises the following steps: crushing forsythia suspense leaves to 80-120 meshes, mixing the crushed forsythia suspense leaves with a betaine-levulinic acid eutectic solvent in a molar ratio of 1: 1-3: 1 according to a material-liquid ratio of 1: 10-1: 35, carrying out stirring extraction at 60-90 DEG C for 0.5-2 h, and carrying out centrifugation and D101 resin purification so as to realize efficient extraction. According to the method, the natural component is used as the solvent, the method is green and environment-friendly, the process is simple and convenient, the cost is low, the yield of forsythin is remarkably increased (1.3%-1.7%), and the yield of forsythiaside A can reach 6.7%-7.4%. The extract can be widely applied to the fields of foods, medicines and cosmetics, and has remarkable economic and social benefits.
Owner:INSTITUTE OF PROCESS ENGINEERING CHINESE ACADEMY OF SCIENCES +1

Method for synchronously and quantitatively detecting 14 components in fructus forsythiae based on ultra-high performance liquid chromatography

The invention discloses a method for synchronously and quantitatively detecting 14 components in fructus forsythiae based on ultra-high performance liquid chromatography, and belongs to the technical field of quality detection of traditional Chinese medicinal materials. Dissolving the fructus forsythiae powder in a methanol aqueous solution, and extracting to obtain a to-be-detected sample; the method comprises the following steps: respectively preparing a standard solution and a mixed standard solution by taking chlorogenic acid, forsythiaside I, forsythiaside B, rutin, forsythiaside A, forsythiaside H, tectoridin, pinoresinol-beta-D-glucoside, naringin, forsythin, arctiin, quercetin, kaempferol and forsythiaside as standard substances; the method comprises the following steps: acquiring a standard curve corresponding to each standard substance, a peak position and a chromatographic result of a to-be-detected sample solution through ultra-high performance liquid chromatography, and substituting the chromatographic result into a standard curve equation of the standard substance; and calculating the contents of chlorogenic acid, forsythiaside I, forsythiaside B, rutin, forsythiaside A, forsythiaside H, tectoridin, pinoresinol-beta-D-glucoside, naringin, forsythin, arctiin, quercetin, kaempferol and forsythiaside in the sample to be detected.
Owner:SHAANXI IOK PHARMA

A quantitative detection method for Ganweikang tablets and its application

The present invention belongs to the technical field of drug detection, and discloses a quantitative detection method and application of Ganweikang tablets. The quantitative detection method comprises the following steps: preparing a reference solution and a test solution; then injecting into a high performance liquid chromatograph for detection, and calculating the content of each component in the test sample according to the peak area of ​​the chromatogram; in the detection, a mobile phase is used for gradient elution, and the mobile phase includes 0.05% to 0.2% formic acid aqueous solution and acetonitrile. The quantitative detection method of Ganweikang tablets provided by the present invention can simultaneously quantitatively determine the content of representative active ingredients in Ganweikang tablets, such as verbena glycosides, cimicifuga glycosides, 5-O-methylvisaminol glycosides, forsythiaside A, forsythiaside, liquiritin, ammonium glycyrrhizinate and calycosin. The quantitative detection method is simple to operate, has strong specificity, good repeatability, and accurate results. It can comprehensively evaluate the quality of Ganweikang tablets and is applied to the quality control and drug development of Ganweikang tablets.
Owner:JIAHENG (ZHUHAI HENGQIN) PHARM TECH CO LTD +1